Webb27 aug. 2024 · by Margarida Maia, PhD August 27, 2024. Shape Therapeutics and Roche have entered into a strategic collaboration and license agreement to develop RNA-based gene therapies for Parkinson’s, Alzheimer’s, and rare diseases. Under the terms of the agreement, Shape will use its proprietary RNA technologies to leverage molecular … Webb25 aug. 2024 · Shape is also entitled to tiered royalty payments on future sales of products developed through the partnership. The alliance will use Shape’s RNA editing platform, RNAfix, and the AAVid technology platform for tissue-specific adeno-associated viruses (AAVs) to create gene therapy for neuroscience and rare disease indications.
Shape Therapeutics Inc CipherBio
WebbShape Therapeutics Inc. 6,587 followers 2mo We are excited to share our newly published review article “RNA editing: Expanding the potential of RNA therapeutics” in Molecular … Webb15 juli 2024 · The Next Big Thing In Gene Therapy Might Not Be Gene Therapy. Gene therapy remains attractive when data show new technologies can advance the field, but gene regulation, editing and RNA therapies are grabbing investors’ attention, panelists said at ARM’s Cell and Gene Meeting on the Mesa. family dollar winter ice air freshener
Base editing marches on the clinic Nature Biotechnology
Webb26 aug. 2024 · 罗氏将向Shape支付总额超过30亿美元的初始和阶段性付款。信贷:Taxiarchos228 / commons.wikimedia.org。 近日,Shape Therapeutics与罗氏(Roche)签署了一项多靶点战略合作伙伴关系和许可协议,以开发针对阿尔茨海默病、帕金森病和罕见疾病领域的特定靶点的基因治疗。 Webb11 jan. 2024 · SEATTLE-- ( BUSINESS WIRE )--Shape Therapeutics Inc. (Shape TX ), a next-generation RNA-targeting gene therapy company, announces today the upcoming … WebbJob Title Research Officer - Cell and Cancer Biologist Job Description An excellent opportunity is available for a Research Officer to join the Spin-out Biologics Company based in the New Medicines and Advanced Technologies Theme at Australia’s pre-eminent biomedical research institute. About the Position An exciting opportunity exists for a … cookies yahemi